Tag: heart disease

  • Report from Maker Faire: Wrist Band Takes Blood Pressure

    Report from Maker Faire: Two students designed a blood-pressure measurement device worn on the wrist to provide continuous readings, something a cuff cannot do.

  • Glucose Drug Reduces Heart Disease in People with Diabetes

    14 June 2016. A drug to reduce glucose levels was shown in a clinical trial to reduce serious heart disease in people with type 2 diabetes also at high risk of heart disease. Results of the late-stage trial testing the drug liraglutide, marketed by drug-maker Novo Nordisk under the brand name Victoza, appear in yesterday’s…

  • Start-Up, Univ. Lab Partner on Computational Drug Discovery

    25 May 2016. A two-year old company developing algorithms for drug discovery is collaborating with University of Chicago medical school to identify candidates to prevent atherosclerosis, or hardening of the arteries. Financial aspects of the agreement between twoXAR Inc. in Palo Alto, California and the lab of Yun Fang at University of Chicago were not…

  • Sensor Patch Tracks Chemical, Physical Vital Signs

    24 May 2016. Engineers at University of California in San Diego developed a patch device worn on the skin with sensors that measure chemical indicators as well as physical vital signs. The UC-San Diego team that designed the device published its findings in yesterday’s issue of the journal Nature Communications. The researchers led by nanoengineering…

  • Personalized Heart Model Devised for Treatment Decisions

    11 May 2016. A medical engineering team developed three-dimensional computer models of the heart that better predict heart rhythm problems requiring an implanted defibrillator than current guidelines. Researchers at Johns Hopkins University led by biomedical engineering professor Natalia Trayanova published its findings yesterday in the journal Nature Communications. Trayanova and colleagues from the Johns Hopkins…

  • Genomic Variations Reveal Cholesterol, Heart Disease Risks

    4 May 2016. A review of genome and blood test records from a large group of people in Iceland identified genetic sequencing variations associated with risk factors connecting cholesterol levels to heart disease. Results of the analysis, conducted by deCode Genetics in Reykjavik, Iceland, appear this week in the journal Nature Genetics (paid subscription required).…

  • Technique Extends Bioactive Device Coating Lifetime

    14 April 2016. A new process is shown to regenerate therapeutic coatings on implanted medical devices in lab tests and with animals, possibly extending the devices’ lifetimes in patients. The techniques, developed in the lab of Harvard University biomedical engineering professor Elliot Chaikof, are described in the 13 April 2016 issue of the journal Nature…

  • NIH Funds Biosensors to Monitor Oxygen in Tissue

    11 April 2016. Profusa Inc., a company designing sensors that measure tissue oxygen levels in individuals with peripheral artery disease, received an NIH grant to advance its technology. The $225,000 Small Business Innovation Research grant for 2016 is divided between two agencies of National Institutes of Health: National Center for Advancing Translational Sciences and National…

  • Stem Cell Biotech Licensing Blood Vessel Repair Technology

    6 April 2016. Cellular Dynamics International, a developer of regenerative treatments from stem cells, is licensing university research that repairs blood vessels in people with peripheral artery disease. Financial aspects of the deal between Indiana University and Cellular Dynamics, a subsidiary of FujiFilm in Madison, Wisconsin, were not disclosed. Cellular Dynamics designs and generates induced…

  • Stem Cells Shown to Improve Heart Failure Health Outcomes

    5 April 2016. Results from a clinical trial show a new therapy for heart failure using patients’ own blood-forming stem cells reduces worsening symptoms, hospitalizations, and deaths. Findings of the study testing the treatments developed by biopharmaceutical company Vericel Corp., which funded the trial, appear in today’s issue of the journal The Lancet (paid subscription…